semaglutide and low potassium Patients Receiving Hemodialysis: Case Reports of Unexpected Benefits for Hyperphosphatemia and Hyperkalemia Low potassium levels in COVID-19

Consult with a health care provider to determine if GLP-1 agonist medications are the right fit for your specific health situation

However, both medications increase heart rate and blood pressure to varying degrees, creating potential cardiovascular risks that single-agent therapy alone avoids

Obesity is a significant health problem among teachers , with one study finding that 70.2% of female school teachers have obesity

Vertigoa spinning sensation that affects balance and spatial awarenessis not listed as a frequent adverse event in major semaglutide clinical trials, yet some patients report dizziness during GLP-1 treatment

Expression cloning of the pancreatic beta cell receptor for the glucoincretin hormone glucagonlike peptide 1